Senior insider sale
Business Development Director at NEUROONE MEDICAL TECHNOLOGIES CORP — senior position signals high conviction
$25.2K
30K shares
What this filing means
CHRISTIANSON MARK plans to sell 30K shares of NEUROONE MEDICAL TECHNOLOGIES CORP valued at approximately $25.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/9/2026ACC: 0001973097-26-000008
Officer· Business Development Director
Since Feb 2026
30K
Shares to sell
$25.2K
Approx. market value
259.80K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Awarded
Awarded
9/3/2024
259.80KTotal acquired259.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/3/2024 | Awarded Awarded | 259.80K | — |
| Total | 259.80K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
30K
Market value
$25.2K
3/9/2026
Total
Units
30K
Value
$25.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/9/2026 | 30K | $25.2K | Nasdaq | Planned |
| Total | 30K | $25.2K | ||